Monroe Capital (MRCC) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
2 Feb, 2026Executive summary
Adjusted net investment income rose to $6.7 million ($0.31 per share), covering the $0.25 per share dividend for the 17th consecutive quarter, with a 14% annualized yield.
Net investment income for Q2 2024 was $6.6 million, or $0.30 per share, up from $5.9 million in Q2 2023.
Net asset value (NAV) declined to $199.3 million ($9.20 per share) from $201.5 million ($9.30 per share) in the prior quarter.
Portfolio quality remained stable, with 80.3% in senior secured loans and 13.0% in equity securities as of June 30, 2024.
Eight borrowers were on non-accrual status at quarter-end, representing 1.9% of total investments at fair value.
Financial highlights
Total investment income for Q2 2024 was $15.6 million, up from $15.2 million in Q1 2024, but down from $16.3 million in Q2 2023.
Total expenses were $9.1 million, down from $9.7 million in Q1 2024, aided by a $1 million incentive fee limitation.
Net loss for the quarter was $3.3 million, mainly due to unrealized mark-to-market losses.
Portfolio at fair value was $485.8 million across 94 companies, with 81.1% in first lien loans.
Distributions to stockholders totaled $0.25 per share for the quarter and $0.50 per share for the six months.
Outlook and guidance
Management expects continued competitive pressure in middle-market lending, with potential for lower yields and weaker covenants.
Market conditions remain favorable for direct lending, but elevated interest rates and a softening macroeconomic environment could increase default rates.
Management remains focused on maintaining asset quality and selectively redeploying capital from repayments.
Latest events from Monroe Capital
- Both asset sale and merger proposals were approved by a majority of outstanding shares.MRCC
EGM 202613 Mar 2026 - Supplemental distributions and enhanced merger terms were approved to address shareholder concerns.MRCC
Proxy Filing11 Mar 2026 - Supplement updates proxy materials for a proposed transaction, referencing recent filings.MRCC
Proxy Filing6 Mar 2026 - Net investment income and NAV declined year-over-year, with merger expected to unlock value.MRCC
Q4 20255 Mar 2026 - Director election and share sale authorization approved; no shareholder questions raised.MRCC
AGM 20243 Feb 2026 - Shareholders to vote on merger and asset sale, with NAV-based share exchange and fee waiver.MRCC
Proxy Filing20 Jan 2026 - Dividend coverage strong, NAV dipped, non-accruals up, Wendel partnership adds $1B capital.MRCC
Q3 202414 Jan 2026 - Q4 income covered dividends; NAV dipped, but 2025 outlook targets growth and risk discipline.MRCC
Q4 202416 Dec 2025 - Shareholders to vote on unchanged advisory agreement after Wendel acquires 75% of Monroe.MRCC
Proxy Filing2 Dec 2025